Skip to Main Content

CERN

CERN Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Income
Balance Sheet
Cash Flow
CERN Income Statement
CERN Balance Sheet
CERN Cash Flow

Recent trades of CERN by members of U.S. Congress

Politician Type Traded
Kevin Hern House / R Sale $15,001 - $50,000 Jun. 10, 2022
Peter Welch House / D Sale $1,001 - $15,000 Nov. 18, 2021
David B. McKinley House / R Sale $15,001 - $50,000 May. 12, 2021
David B. McKinley House / R Sale $15,001 - $50,000 Mar. 24, 2021
David B. McKinley House / R Purchase $1,001 - $15,000 Feb. 22, 2021
David B. McKinley House / R Sale $1,001 - $15,000 Oct. 05, 2020
Dean Phillips House / D Sale $1,001 - $15,000 Feb. 28, 2020
Cynthia Axne House / D Sale $1,001 - $15,000 Feb. 27, 2020
Dean Phillips House / D Sale $1,001 - $15,000 Feb. 27, 2020
Cynthia Axne House / D Sale $1,001 - $15,000 Feb. 27, 2020
Cynthia Axne House / D Sale $1,001 - $15,000 Feb. 27, 2020
Dean Phillips House / D Sale $1,001 - $15,000 Feb. 26, 2020
Mikie Sherrill House / D Sale $1,001 - $15,000 Feb. 20, 2020
Dean Phillips House / D Sale $1,001 - $15,000 Feb. 14, 2020
Dean Phillips House / D Sale $1,001 - $15,000 Feb. 10, 2020
Dean Phillips House / D Sale $1,001 - $15,000 Aug. 02, 2019
Dean Phillips House / D Sale $1,001 - $15,000 Aug. 01, 2019
Dean Phillips House / D Sale $1,001 - $15,000 Jul. 22, 2019
Lizzie Fletcher House / D Sale $1,001 - $15,000 Jul. 09, 2019
Dean Phillips House / D Sale $1,001 - $15,000 Jun. 11, 2019
Lizzie Fletcher House / D Sale $1,001 - $15,000 May. 31, 2019
Dean Phillips House / D Sale $1,001 - $15,000 Apr. 04, 2019
Dean Phillips House / D Purchase $1,001 - $15,000 Mar. 15, 2019
David B. McKinley House / R Sale $1,001 - $15,000 Jan. 14, 2019
David B. McKinley House / R Purchase $15,001 - $50,000 Jan. 14, 2019
David B. McKinley House / R Purchase $1,001 - $15,000 Dec. 20, 2018
Peter Welch House / D Purchase $1,001 - $15,000 Jun. 07, 2018
Peter Welch House / D Sale $1,001 - $15,000 Apr. 25, 2018
Shelley Moore Capito Senate / R Sale (Full) $1,001 - $15,000 Feb. 27, 2018
David B. McKinley House / R Purchase $1,001 - $15,000 Sep. 14, 2017
Shelley Moore Capito Senate / R Purchase $1,001 - $15,000 Sep. 08, 2017
Lamar Smith House / R Sale $1,001 - $15,000 Mar. 16, 2017
James M. Inhofe Senate / R Sale (Full) $50,001 - $100,000 Feb. 10, 2017
Cheri Bustos House / D Sale $15,001 - $50,000 Jan. 30, 2017
Thomas R. Suozzi House / D Sale $15,001 - $50,000 Jan. 05, 2017
Lamar Smith House / R Sale $1,001 - $15,000 Jan. 05, 2017
David B. McKinley House / R Sale $15,001 - $50,000 Dec. 21, 2016
James M. Inhofe Senate / R Purchase $50,001 - $100,000 Dec. 01, 2016
David B. McKinley House / R Sale $1,001 - $15,000 Oct. 17, 2016
Sheldon Whitehouse Senate / D Sale (Full) $1,001 - $15,000 May. 18, 2016
Lamar Smith House / R Purchase $1,001 - $15,000 Jan. 28, 2016
Lamar Smith House / R Purchase $1,001 - $15,000 Dec. 15, 2015
David B. McKinley House / R Purchase $15,001 - $50,000 Sep. 18, 2015
David B. McKinley House / R Purchase $1,001 - $15,000 Sep. 18, 2015
K. Michael Conaway House / R Purchase $1,001 - $15,000 Aug. 05, 2015
Lamar Smith House / R Purchase $1,001 - $15,000 Feb. 10, 2015
Lamar Smith House / R Purchase $1,001 - $15,000 Feb. 03, 2015
Thomas MacArthur House / R Sale $1,001 - $15,000 Jan. 27, 2015
David B. McKinley House / R Purchase $1,001 - $15,000 Mar. 07, 2014
CERN Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
CERN Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
CERN Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by CERN's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

  • $160,000 Apr 19, 2022 Issue: Budget/Appropriations Health Issues Veterans Defense
  • $160,000 Jan 20, 2022 Issue: None
  • $150,000 Oct 20, 2021 Issue: None
  • $150,000 Jul 20, 2021 Issue: None
  • $150,000 Apr 20, 2021 Issue: None
  • $140,000 Jan 20, 2021 Issue: None
  • $140,000 Oct 20, 2020 Issue: None
  • $140,000 Jul 20, 2020 Issue: None
  • $140,000 Apr 20, 2020 Issue: None
  • $130,000 Jan 21, 2020 Issue: None
  • $140,000 Apr 22, 2019 Issue: Veterans Budget/Appropriations Defense Health Issues
  • $140,000 Jan 22, 2019 Issue: Budget/Appropriations Health Issues Defense Veterans
  • $130,000 Jul 20, 2018 Issue: Health Issues Veterans Budget/Appropriations Defense
  • $110,000 Apr 19, 2018 Issue: Budget/Appropriations Defense Health Issues Veterans
  • $150,000 Jan 22, 2018 Issue: Health Issues Veterans Defense
  • $70,000 Oct 19, 2017 Issue: Veterans Defense Health Issues
  • $70,000 Oct 19, 2017 Issue: Health Issues Veterans Defense
  • $150,000 Oct 19, 2017 Issue: Veterans Defense Health Issues
  • $10,000 Jan 23, 2017 Issue: Defense Health Issues Veterans
  • $40,000 Jan 18, 2017 Issue: Budget/Appropriations Health Issues Defense
  • $10,000 Jan 19, 2016 Issue: Defense Health Issues Veterans
  • $40,000 Jan 14, 2016 Issue: Defense Health Issues Budget/Appropriations
  • $10,000 Oct 20, 2015 Issue: Health Issues Defense Veterans
  • $50,000 Oct 09, 2015 Issue: Health Issues Defense
  • $10,000 Jul 17, 2015 Issue: Veterans Health Issues Defense
  • $50,000 Jul 07, 2015 Issue: Veterans Defense Health Issues
  • $10,000 Apr 17, 2015 Issue: Health Issues
  • $50,000 Apr 07, 2015 Issue: Defense Health Issues Veterans
  • $20,000 Jan 20, 2015 Issue: Health Issues
  • $50,000 Jan 15, 2015 Issue: Veterans Defense Health Issues
  • $20,000 Oct 16, 2014 Issue: Health Issues
  • $50,000 Oct 16, 2014 Issue: Defense Health Issues Veterans
  • $50,000 Jul 16, 2014 Issue: Defense Health Issues
  • $20,000 Jul 14, 2014 Issue: Health Issues
  • $20,000 Apr 16, 2014 Issue: Health Issues
  • $50,000 Apr 16, 2014 Issue: Health Issues Defense
  • $60,000 Jan 15, 2014 Issue: Defense Health Issues
  • $20,000 Oct 18, 2013 Issue: Defense Health Issues
  • $50,000 Apr 20, 2010 Issue: None
  • $50,000 Jan 19, 2010 Issue: None
  • $65,000 Oct 22, 2009 Issue: Health Issues
  • $180,000 Sep 02, 2009 Issue: Health Issues
  • $65,000 Jul 10, 2009 Issue: Health Issues
  • $50,000 Jan 20, 2009 Issue: Health Issues
  • $40,000 Oct 20, 2008 Issue: Health Issues
  • $45,000 Jul 10, 2008 Issue: Health Issues
  • $180,000 Apr 22, 2008 Issue: Health Issues
  • $180,000 Feb 05, 2008 Issue: Health Issues
  • $160,000 Aug 08, 2007 Issue: Health Issues
  • $60,000 Mar 16, 2007 Issue: Health Issues
  • $40,000 Feb 09, 2007 Issue: Budget/Appropriations
  • $60,000 Aug 11, 2006 Issue: Budget/Appropriations
  • $120,000 Feb 14, 2006 Issue: Budget/Appropriations
  • $40,000 Aug 15, 2005 Issue: Budget/Appropriations
  • $120,000 Feb 14, 2005 Issue: Budget/Appropriations
  • $60,000 Aug 03, 2004 Issue: Budget/Appropriations
  • $20,000 Aug 13, 2003 Issue: Health Issues
  • $40,000 Aug 14, 2000 Issue: Health Issues Medicare/Medicaid Pharmacy

Estimated quarterly lobbying spending

U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

WallStreetBets

Number of mentions of CERN in WallStreetBets Daily Discussion

CERN News

Recent insights relating to CERN

CNBC Recommendations

Recent picks made for CERN stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in CERN

CERN Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view CERN Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top